CCC

Citius Oncology, Inc.

No trades
See on Supercharts

CTOR fundamentals

An in-depth look to Citius Oncology, Inc. operating, investing, and financing activities

CTOR free cash flow for Q2 24 is -364.06 k USD. For 2023, CTOR free cash flow was -601.3 k USD and operating cash flow was -601.3 k USD.

Q1 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth